Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") (RU)
发明人:
Тарасова Элина Николаевна (RU),Савельева Ольга Дмитриевна (RU),Питькин Андрей Сергеевич (RU),Алёшина Елена Юрьевна (RU),Штылева Светлана Валентиновна (RU)
申请号：
RU2013157796/15
公开号：
RU2013157796A
申请日:
2013.12.26
申请国别(地区):
RU
年份:
2015
代理人:
摘要：
1. A pharmaceutical composition comprising a therapeutically effective amount of moxifloxacin and pharmaceutically acceptable excipients, characterized in that it further comprises pirazinamid.2. A pharmaceutical composition according to claim 1, characterized in that it comprises moxifloxacin as moxifloxacin gidrohlorid.3. A pharmaceutical composition according to claim 1, characterized in that it comprises moxifloxacin and pirazimnamid in the following ratio, parts by weight: 4. A pharmaceutical composition according to claim 3, characterized in that it is formed as a solid dosage formy.5. A pharmaceutical composition according to claim 4, characterized in that it is in the form tabletki.6. A pharmaceutical composition according to claim 5, characterized in that it has obolochku.7. A pharmaceutical composition according to claim 6, characterized in that it has a film obolochku.8. A pharmaceutical composition according to any one of claims 5-7, characterized in that it contains ingredients of the active ingredient in a unit dose in the following amount, mg: Pyrazinamide - 5 800 ± 9%. A pharmaceutical composition according to any one of claims 5-7, characterized in that it comprises as excipients a binder, disintegrant, filler and lubrikant10. A pharmaceutical composition according to claim 9, characterized in that it comprises additionally glidant.11. Use of a combination of moxifloxacin and pyrazinamide for the manufacture of a pharmaceutical composition according to any one pp.1-9.12. Pharmaceutical composition according to any of claims 1-9 for the treatment of tuberculosis.1. Фармацевтическая композиция, включающая терапевтически эффективное количество моксифлоксацина и фармацевтически приемлемые вспомогательные вещества, отличающаяся тем, что дополнительно содержит пиразинамид.2. Фармацевтическая композиция по п.1, характеризующаяся тем, что содержит в качестве моксифлоксацина моксифлоксацина гидрохлорид.3. Фармацевтическая композиция по п.1, характеризующаяся
